For example, the Dose Adjustment for Normal Eating (DAFNE) study, with a flexible and intensive 5-day single course in the treatment of adults with type 1 diabetes with insulin, provided major long-term benefits for quality of life outcomes and treatment satisfaction. The gene discussed is INS; the disease is type 1 diabetes mellitus.